Ischemia‐modified albumin: origins and clinical implications

A Shevtsova, I Gordiienko, V Tkachenko… - Disease …, 2021 - Wiley Online Library
Albumin is one of the most abundant proteins in the body of mammals: about 40% of its pool
is located in the intravascular space and the remainder is found in the interstitial space. The …

Pineapple consumption reduced cardiac oxidative stress and inflammation in high cholesterol diet-fed rats

P Seenak, S Kumphune, W Malakul, R Chotima… - Nutrition & …, 2021 - Springer
Background Hypercholesterolemia is a major risk factor for cardiovascular disease. It has
been reported that pineapple contains healthy nutrients and phytochemicals associated with …

[HTML][HTML] Role of “Ischemia Modified Albumin”(IMA) in acute coronary syndromes

CB Reddy, C Cyriac, HB Desle - Indian heart journal, 2014 - Elsevier
Background Diagnosis of acute coronary syndrome (ACS) is important, due to the
associated very high mortality. Failure to diagnose ACS is a problem both for the patients …

Post-ischemic treatment of recombinant human secretory leukocyte protease inhibitor (rhSLPI) reduced myocardial ischemia/reperfusion injury

P Mongkolpathumrat, A Kijtawornrat, E Prompunt… - Biomedicines, 2021 - mdpi.com
Myocardial ischemia/reperfusion (I/R) injury is a major cause of mortality and morbidity
worldwide. Among factors contributing to I/R injury, proteolytic enzymes could also cause …

Utility of ischemia modified albumin as an early marker for diagnosis of acute coronary syndrome

B Mishra, S Pandey, SR Niraula, BK Rai… - Journal of Nepal Health …, 2018 - nepjol.info
Background: The diagnosis of acute coronary syndrome remains challenging, as cardiac
troponins and creatine kinase-MB do not detect myocardial ischemia. Ischemia modified …

Adeno-associated virus 9 vector-mediated cardiac-selective expression of human secretory leukocyte protease inhibitor attenuates myocardial ischemia/reperfusion …

P Mongkolpathumrat, N Nernpermpisooth… - Frontiers in …, 2022 - frontiersin.org
Protease enzymes contribute to the initiation of cardiac remodeling and heart failure after
myocardial ischemic/reperfusion (I/R) injury. Protease inhibitors attenuate protease activity …

[HTML][HTML] The clinical assessment of ischaemia modified albumin and troponin I in the early diagnosis of the acute coronary syndrome

SM Patil, MP Banker, RK Padalkar… - Journal of clinical and …, 2013 - ncbi.nlm.nih.gov
Background: An early identification of the patients with the Acute Coronary Syndrome (ACS)
is of prime importance, due to the associated very high mortality. Only about 22% of the …

Cardioprotective Effect of Empagliflozin in Rats with Isoproterenol-Induced Myocardial Infarction: Evaluation of Lipid Profile, Oxidative Stress, Inflammation, DNA …

M Ekici, H Güngör, MÖ Karayığıt, NH Turgut… - Biology Bulletin, 2022 - Springer
The antidiabetic drug empagliflozin is reported to have many cardioprotective effects.
However, no studies have investigated the protective effects of empagliflozin (EMPA) in …

The clinical significance of ischaemia-modified albumin in acute coronary syndrome and hypertension

G Pan, J Chen, C Lv, X Lin, J Huang, B Lin… - Cardiology in the …, 2024 - cambridge.org
Background: Early diagnosis of acute coronary syndrome is more and more important
because of its mortality and morbidity. Hypertension is one of the pathogenesis of acute …

Role of ischemia-modified albumin in clinical practice

AK Erenler, T Yardan, C Kati, M Altuntaş… - …, 2015 - degruyter.com
Difficulty in establishing a diagnosis of acute coronary syndrome (ACS) in the clinical setting
has led researchers to investigate novel markers that show increased blood levels before …